SHINYA WATANABE

Has grant

Lecturer

University of Tsukuba

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Research Cancer Research professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

脳腫瘍領域における臨床評価手法に関するレギュラトリーサイエンス研究

Open Date: 2022-04-01

Close Date: 2025-03-31

Grant: Close

分化誘導神経系細胞より作製する血管内在神経束を用いた生着型新規再生医療の創出

Open Date: 2021-04-01

Close Date: 2024-03-31

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

Assistant Professor

University of Tsukuba

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SHINYA WATANABE

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

A retrospective cohort study of stereotactic radiosurgery for vestibular schwannomas: Comparison of two age groups (75 years or older vs. 65-74 years).

[Challenges to Overcome in Clinical Research on Meningiomas].

Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints

A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology

Development of the Neurotrainer, a Cognitive Training System Based on Neurofeedback of Single-trial Event-related Potentials

Empirical Myoelectric Feature Extraction and Pattern Recognition in Hemiplegic Distal Movement Decoding

Idiopathic Normal Pressure Hydrocephalus With Multiple Sulcus Enlargements but No Ventricular Enlargement Resembling Brain Atrophy Over a Long Period Before Diagnosis: A Case Report.

Brain Abscess Due to Dental Sinusitis: A Case Report on Incomplete Infection Defense Associated With a Post-Fusion Linear Skull Fracture.

Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials

P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients.

Collaborators (5)

Yasushi Shibata

Kenji Suzuki

Hideki Kadone

Alexander Zaboronok

Hiroki Watanabe

Make your next move.